MiMedx Financial Statements From 2010 to 2024

MDXG Stock  USD 7.70  0.09  1.18%   
MiMedx financial statements provide useful quarterly and yearly information to potential MiMedx Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MiMedx financial statements helps investors assess MiMedx's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MiMedx's valuation are summarized below:
Gross Profit
219.5 M
Profit Margin
0.1811
Market Capitalization
1.1 B
Enterprise Value Revenue
3.3779
Revenue
321.5 M
There are over one hundred nineteen available fundamental ratios for MiMedx, which can be analyzed over time and compared to other ratios. Active traders should verify all of MiMedx last-minute fundamental drivers against the trend between 2010 and 2024 to make sure the company can sustain itself down the road.
Check MiMedx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MiMedx main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 M, Interest Expense of 6.8 M or Selling General Administrative of 123.2 M, as well as many exotic indicators such as Short Term Coverage Ratios of 18.16, Price Earnings Ratio of 19.93 or Price To Sales Ratio of 3.78. MiMedx financial statements analysis is a perfect complement when working with MiMedx Valuation or Volatility modules.
  
This module can also supplement MiMedx's financial leverage analysis and stock options assessment as well as various MiMedx Technical models . Check out the analysis of MiMedx Correlation against competitors.

MiMedx Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets251 M239 M133.6 M
Slightly volatile
Short and Long Term Debt Total25 M48.1 M45.7 M
Slightly volatile
Other Current Liabilities22.9 M37 M26.4 M
Slightly volatile
Total Current Liabilities30.6 M46 M35.3 M
Slightly volatile
Accounts Payable7.5 MM7.3 M
Slightly volatile
Cash86.1 M82 M46.6 M
Slightly volatile
Non Current Assets Total78.5 M74.8 M41.9 M
Slightly volatile
Non Currrent Assets Other194.8 K205 K631.8 K
Very volatile
Cash And Short Term Investments86.1 M82 M47.2 M
Slightly volatile
Common Stock Total Equity96.6 K101.7 K101.3 K
Slightly volatile
Common Stock Shares Outstanding94.7 M146 M99.9 M
Slightly volatile
Liabilities And Stockholders Equity251 M239 M133.6 M
Slightly volatile
Non Current Liabilities Total32.2 M50.3 M36.9 M
Slightly volatile
Other Current Assets2.5 M1.7 M2.8 M
Slightly volatile
Total Liabilities62.8 M96.3 M72.1 M
Slightly volatile
Total Current Assets172.5 M164.3 M91.7 M
Slightly volatile
Intangible Assets9.5 M5.3 M9.7 M
Pretty Stable
Common Stock99.6 K146 K102.8 K
Slightly volatile
Property Plant And Equipment Net8.2 M9.1 M9.5 M
Slightly volatile
Good Will11.8 M19.4 M12.8 M
Slightly volatile
Property Plant And Equipment Gross30.6 M29.1 M12.3 M
Slightly volatile
Short Term Debt1.3 M1.5 M1.3 M
Slightly volatile
Net Receivables56.6 M53.9 M27.7 M
Slightly volatile
Inventory22.1 M21 M10.5 M
Slightly volatile
Other Liabilities2.6 M2.1 M3.2 M
Pretty Stable
Long Term Debt Total74.8 M71.2 M51.6 M
Slightly volatile
Capital Surpluse157.7 M190.5 M145.8 M
Slightly volatile
Property Plant Equipment10.9 M12.9 M9.5 M
Slightly volatile
Long Term Investments2.6 M2.9 M3.2 M
Slightly volatile
Short and Long Term Debt4.5 M4.3 M2.1 M
Slightly volatile
Non Current Liabilities Other3.2 M2.2 M6.2 M
Slightly volatile
Net Invested Capital200.4 M190.8 M83.8 M
Slightly volatile
Net Working Capital75.1 M118.3 M38.2 M
Slightly volatile
Capital Stock138.7 K146 K12.4 M
Slightly volatile
Warrants101.2 M106.4 M93.3 M
Slightly volatile

MiMedx Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.6 M3.4 M3.9 M
Slightly volatile
Selling General Administrative123.2 M206.7 M140.8 M
Slightly volatile
Other Operating Expenses169.4 M284.4 M194.2 M
Slightly volatile
Research Development10 M12.7 M10.8 M
Slightly volatile
Total Operating Expenses146.3 M229.7 M167.5 M
Slightly volatile
Total Revenue218.5 M321.5 M200 M
Slightly volatile
Cost Of Revenue29.7 M54.6 M27.2 M
Slightly volatile
Reconciled Depreciation4.6 M3.6 M5.7 M
Slightly volatile
Non Recurring45.3 K47.7 K379.1 K
Slightly volatile

MiMedx Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Cashflows From Financing ActivitiesM997 K10.1 M
Pretty Stable
Depreciation3.6 M3.4 M3.9 M
Slightly volatile
Capital Expenditures3.6 M2.2 MM
Pretty Stable
End Period Cash Flow86.1 M82 M44.8 M
Slightly volatile
Begin Period Cash Flow33.7 M66 M36.3 M
Slightly volatile
Stock Based Compensation11.9 M17 M11.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.783.981911.9972
Slightly volatile
Dividend Yield7.0E-48.0E-40.0073
Pretty Stable
Operating Cycle209202191
Pretty Stable
Days Of Payables Outstanding10360.448193.33
Slightly volatile
Inventory Turnover4.372.5993.9946
Slightly volatile
Ebt Per Ebit0.910.82531.1564
Very volatile
Payables Turnover3.386.03824.1538
Slightly volatile
Long Term Debt To Capitalization0.440.25210.6593
Slightly volatile
Cash Per Share0.320.56180.4912
Pretty Stable
Total Debt To Capitalization0.190.25810.6519
Pretty Stable
Quick Ratio3.442.95322.9027
Slightly volatile
Net Income Per E B T1.462.20151.6407
Pretty Stable
Cash Ratio2.641.78231.9798
Slightly volatile
Cash Conversion Cycle121141111
Slightly volatile
Days Of Inventory Outstanding135140124
Very volatile
Days Of Sales Outstanding73.8761.164367.599
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.870.91951.78
Pretty Stable
Current Ratio4.613.57033.3811
Pretty Stable
Fixed Asset Turnover37.0735.303920.1788
Slightly volatile
Debt Ratio0.20.20770.3292
Slightly volatile
Price Sales Ratio3.783.981911.9972
Slightly volatile
Receivables Turnover5.675.967589.8021
Very volatile
Asset Turnover1.061.34481.3016
Slightly volatile

MiMedx Fundamental Market Drivers

Forward Price Earnings23.8095
Cash And Short Term Investments82 M

MiMedx Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MiMedx Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include MiMedx income statement, its balance sheet, and the statement of cash flows. MiMedx investors use historical funamental indicators, such as MiMedx's revenue or net income, to determine how well the company is positioned to perform in the future. Although MiMedx investors may use each financial statement separately, they are all related. The changes in MiMedx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MiMedx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MiMedx Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MiMedx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue-1.5 M-1.6 M
Total Revenue321.5 M218.5 M
Cost Of Revenue54.6 M29.7 M
Ebit Per Revenue 0.12  0.12 

MiMedx Investors Sentiment

The influence of MiMedx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in MiMedx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to MiMedx's public news can be used to forecast risks associated with an investment in MiMedx. The trend in average sentiment can be used to explain how an investor holding MiMedx can time the market purely based on public headlines and social activities around MiMedx Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
MiMedx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for MiMedx's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average MiMedx's news discussions. The higher the estimated score, the more favorable is the investor's outlook on MiMedx.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MiMedx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MiMedx's short interest history, or implied volatility extrapolated from MiMedx options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out the analysis of MiMedx Correlation against competitors.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for MiMedx Stock analysis

When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is MiMedx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4
Earnings Share
0.43
Revenue Per Share
2.76
Quarterly Revenue Growth
0.167
Return On Assets
0.113
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.